Literature DB >> 16113553

Identification of maternal hematopoietic cells in a 2nd-trimester fetus.

Cecilia Götherstrom1, Anna Maria Johnsson, Jonas Mattsson, Nikos Papadogiannakis, Magnus Westgren.   

Abstract

OBJECTIVE: To study the subset of maternal cells in fetal tissue in a 2nd-trimester fetus with malformations.
METHODS: By cell sorting and PCR amplification, we studied the presence of maternal CD3+ (T cells), CD19+ (B cells), CD34+ (hematopoietic progenitor cells), and CD45+ (leukocytes) in different tissues in a 2nd trimester fetus.
RESULTS: Maternal cells could be detected in fetal liver, lung, heart, thymus, spleen, adrenal gland, kidney, and placenta, but not in pancreas or gonadal tissue. In thymus, liver, and spleen, cell separation showed CD3+, CD19+, CD34+, and CD45+ positive cells of maternal origin.
CONCLUSIONS: The present study indicates that maternal cells are widely distributed in a 2nd-trimester fetus. In addition, we found subpopulations of maternal cells belonging to lymphoid and myeloid lineages and hematopoietic progenitors with engraftment capacity in liver, spleen, and thymus. The study warrants further investigations on presence and possible biological function of maternal cells in normal and malformed fetuses. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16113553     DOI: 10.1159/000086812

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  10 in total

1.  Effect of parity on fetal and maternal microchimerism: interaction of grafts within a host?

Authors:  Hilary S Gammill; Katherine A Guthrie; Tessa M Aydelotte; Kristina M Adams Waldorf; J Lee Nelson
Journal:  Blood       Date:  2010-07-13       Impact factor: 22.113

Review 2.  Microchimerism in endocrine pathology.

Authors:  Daniel W Rust; Diana W Bianchi
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943

Review 3.  Heterogeneous pathways of maternal-fetal transmission of human viruses (review).

Authors:  A Saleh Younes; Márta Csire; Beatrix Kapusinszky; Katalin Szomor; Mária Takács; György Berencsi
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

Review 4.  Naturally acquired microchimerism.

Authors:  Hilary S Gammill; J Lee Nelson
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

5.  In utero transplanted human hepatocytes allow postnatal engraftment of human hepatocytes in pigs.

Authors:  James E Fisher; Joseph B Lillegard; Travis J McKenzie; Brian R Rodysill; Peter J Wettstein; Scott L Nyberg
Journal:  Liver Transpl       Date:  2013-03       Impact factor: 5.799

6.  Maternal and Fetal Immune Response to in Utero Stem Cell Transplantation.

Authors:  Amir Alhajjat; Aimen Shaaban
Journal:  Curr Stem Cell Rep       Date:  2018-05-03

7.  Mother and child T cell receptor repertoires: deep profiling study.

Authors:  Ekaterina V Putintseva; Olga V Britanova; Dmitriy B Staroverov; Ekaterina M Merzlyak; Maria A Turchaninova; Mikhail Shugay; Dmitriy A Bolotin; Mikhail V Pogorelyy; Ilgar Z Mamedov; Vlasta Bobrynina; Mikhail Maschan; Yuri B Lebedev; Dmitriy M Chudakov
Journal:  Front Immunol       Date:  2013-12-25       Impact factor: 7.561

8.  Human Umbilical Vein Endothelial Cells foster conversion of CD4+CD25-Foxp3- T cells into CD4+Foxp3+ Regulatory T Cells via Transforming Growth Factor-β.

Authors:  Anika Oettel; Mario Lorenz; Verena Stangl; Serban-Dan Costa; Ana Claudia Zenclussen; Anne Schumacher
Journal:  Sci Rep       Date:  2016-03-18       Impact factor: 4.379

9.  Determining the extent of maternal-foetal chimerism in cord blood.

Authors:  Rianne Opstelten; Manon C Slot; Neubury M Lardy; Arjan C Lankester; Arend Mulder; Frans H J Claas; Jon J van Rood; Derk Amsen
Journal:  Sci Rep       Date:  2019-03-27       Impact factor: 4.379

10.  Male microchimerism in the human female brain.

Authors:  William F N Chan; Cécile Gurnot; Thomas J Montine; Joshua A Sonnen; Katherine A Guthrie; J Lee Nelson
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.